Pulmagen Therapeutics is a development stage pharmaceutical company progressing novel therapies to treat chronic respiratory diseases including asthma, severe asthma, and COPD. ** Click here for ERS 2013 Posters **

ss1 ss2 ss3 ss4 ss5 ss6 ss7 ss8 ss8


Pulmagen intends to progress its programs through Phase II proof-of-concept clinical trials and identify strategic partners for later stage clinical development.

The company has active partnered respiratory drug development programs with AstraZeneca, Chiesi, Dr. Reddy's and Teijin.


Pulmagen Partners